Drug-induced Liver Injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report
Ann. hepatol; 16 (2), 2017
ABSTRACT A 75-year old male patient had been regularly visiting our hospital for the management of his type 2 diabetes mellitus since he was diagnosed at age 64 years. When he developed hypoglycemic episodes with sulfonylurea, ipragliflozin (50 mg/day) was started to replace the sulfonylurea therapy. How...
Enfermedad Hepática Inducida por Sustancias y Drogas/diagnóstico, Enfermedad Hepática Inducida por Sustancias y Drogas/inmunología, Enfermedad Hepática Inducida por Sustancias y Drogas/etiología, Diabetes Mellitus Tipo 2/tratamiento farmacológico, Glucósidos/efectos adversos, Hipoglucemiantes/efectos adversos, Activación de Linfocitos/efectos de los fármacos, Tiofenos/efectos adversos, Enfermedad Hepática Inducida por Sustancias y Drogas/terapia, Diabetes Mellitus Tipo 2/sangre, Diabetes Mellitus Tipo 2/diagnóstico, Pruebas de Función Hepática, Valor Predictivo de las Pruebas, Factores de Riesgo